Aid for AIDS
INDIA will start clinical trials this year of the anti-HIV drug, AZT, on pregnant women, despite high costs and doubts about its efficacy. The trials will be conducted in Mumbai, Tamil Nadu and Kerala, say officials at the Union government's National AIDS Control Organisation (NACO), The government has identified these centres because of the existing large number of hospital cases reported in these places, said J V R Prasad Rao, additional director general of NACO. The government is also finalising a list of research institutes that would supervise the trials, he said.
The tests are being car-ried to double-check the success of AZT on mv-posi-tive pregnant women con-ducted in countries around the world including Thailand, said D Sengupta, advisor to NACO. He says the drug, a 'protease-blocker' when admin-istered from six months of pregnancy onwards, reduces the viral load in the mother's blood.
Related Content
- Development of a framework to identify research priorities for mitigating the impact of climate change on HIV response in India
- Report on behalf of Pune Municipal Corporation (PMC) on the use of enzyme Draynzyme to clean waterbodies, 04/04/2024
- 2024 water funding gap report
- HIV drug resistance: brief report 2024
- Counting the cost 2023: a year of climate breakdown
- Renewables readiness assessment: Burkina Faso